Literature DB >> 21053099

A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China.

Miao-Zhen Qiu1, Dong-Sheng Zhang, Dan-Yun Ruan, Hui-Yan Luo, Zhi-Qiang Wang, Zhi-Wei Zhou, Feng-Hua Wang, Yu-Hong Li, Rui-Hua Xu.   

Abstract

Little is known about the relationship between ABO blood groups and the clinicopathologic features in gastric adenocarcinoma patients of China. Whether the distribution of ABO blood groups in patients with gastric adenocarcinoma differs from that with benign diseases is also unknown. A total of 474 gastric adenocarcinoma patients and 404 with benign diseases were enrolled for the study. The relationship between patients' ABO blood groups and the clinicopathologic features was analyzed. The percentage of blood group AB was more common in men of gastric cancer than in benign diseases. The proportion of angiolymphatic invasion among patients with blood group O was significantly lower than those with other blood groups (P = 0.034). Proportion of tumors associated with estrogen receptor (ER), progestogen receptor (PR) and carcinoembryonic antigen (CEA) expression in blood type A was significantly higher than in other blood types (P = 0.002 for ER expression, 0.009 for PR expression, 0.003 for CEA expression). Proportion of tumors associated with serum CEA and CA19-9 elevation in blood type AB was significantly lower than in other blood types (P < 0.001 for serum CEA elevation, 0.005 for CA19-9 elevation). Though there was no significant difference between ABO blood groups and survival of the patients, patients with blood group B had a trend to show superiority in the survival. The significance of ABO blood group distribution might be associated with biological behavior of gastric adenocarcinoma patients. However, it was found not to be a prognosis factor for patients with gastric adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21053099     DOI: 10.1007/s12032-010-9735-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  32 in total

1.  Expression of A, B, and H blood group antigens in epithelial ovarian cancer: relationship to tumor grade and patient survival.

Authors:  M Welshinger; C L Finstad; E Venkatraman; M G Federici; S C Rubin; J L Lewis; K O Lloyd
Journal:  Gynecol Oncol       Date:  1996-07       Impact factor: 5.482

2.  ABO blood groups and cancer.

Authors:  G R Newell; J E Gordon; A P Monlezun; J S Horwitz
Journal:  J Natl Cancer Inst       Date:  1974-05       Impact factor: 13.506

3.  Correlation of low serum IgM levels with absence of functional splenic tissue in sickle cell disease syndromes.

Authors:  P Gavrilis; S P Rothenberg; R Guy
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

4.  Immunohistochemical studies of blood group-related antigens in human superficial esophageal carcinomas.

Authors:  K Tauchi; K Kakudo; T Machimura; H Makuuchi; T Mitomi
Journal:  Cancer       Date:  1991-06-15       Impact factor: 6.860

5.  Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy.

Authors:  S S Robey-Cafferty; A K el-Naggar; A A Sahin; J M Bruner; J Y Ro; K R Cleary
Journal:  Am J Clin Pathol       Date:  1991-06       Impact factor: 2.493

6.  Correlation of ABO blood group with clinicopathologic characteristics of patients with esophageal squamous cell carcinoma.

Authors:  T Nozoe; T Ezaki; H Baba; Y Kakeji; Y Maehara
Journal:  Dis Esophagus       Date:  2004       Impact factor: 3.429

7.  Loss of blood group antigen A in non-small cell lung cancer.

Authors:  J L Gwin; A J Klein-Szanto; S Y Zhang; P Agarwal; A Rogatko; S M Keller
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

8.  [Pancreatic cancer and ABO blood types: a study of cases and controls].

Authors:  J Vioque; A M Walker
Journal:  Med Clin (Barc)       Date:  1991-05-25       Impact factor: 1.725

9.  Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.

Authors:  S L Graziano; A H Tatum; N J Gonchoroff; N B Newman; L J Kohman
Journal:  Clin Cancer Res       Date:  1997-01       Impact factor: 12.531

10.  Blood group as a prognostic indicator in breast cancer.

Authors:  P J Holdsworth; J Thorogood; E A Benson; A D Clayden
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-02
View more
  12 in total

1.  Relationship between ABO blood group and clinicopathological factors and their effect on the survival of Japanese patients with esophageal squamous cell carcinoma.

Authors:  Fumiaki Shiratori; Hideaki Shimada; Satoshi Yajima; Takashi Suzuki; Yoko Oshima; Tatsuki Nanami; Masaaki Ito; Hironori Kaneko
Journal:  Surg Today       Date:  2016-12-27       Impact factor: 2.549

2.  The ABO blood group predicts survival in esophageal squamous cell carcinoma in patients who ever smoked: a retrospective study from China.

Authors:  Peng Sun; Cui Chen; Fei Zhang; Xin An; Xiu-Yue Li; Yu-Hong Li; Zhi-Hua Zhu; Feng-Hua Wang
Journal:  Tumour Biol       Date:  2014-04-27

3.  ABO blood group and risk of renal cell cancer.

Authors:  Hee-Kyung Joh; Eunyoung Cho; Toni K Choueiri
Journal:  Cancer Epidemiol       Date:  2012-07-26       Impact factor: 2.984

Review 4.  The prognostic value of ABO blood group in cancer patients.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

5.  Prognostic Impact of ABO Blood Group on the Survival in Patients with Ovarian Cancer.

Authors:  Juan Zhou; Li-Chao Yang; Zhen-Yu He; Fang-Yan Li; San-Gang Wu; Jia-Yuan Sun
Journal:  J Cancer       Date:  2015-08-08       Impact factor: 4.207

6.  Impact of ABO blood group on the prognosis of patients undergoing surgery for esophageal cancer.

Authors:  Wei Wang; Lei Liu; Zhiwei Wang; Min Wei; Qi He; Tianlong Ling; Ziang Cao; Yixin Zhang; Qiang Wang; Minxin Shi
Journal:  BMC Surg       Date:  2015-09-29       Impact factor: 2.102

7.  ABO blood group system and gastric cancer: a case-control study and meta-analysis.

Authors:  Zhiwei Wang; Lei Liu; Jun Ji; Jianian Zhang; Min Yan; Jun Zhang; Bingya Liu; Zhenggang Zhu; Yingyan Yu
Journal:  Int J Mol Sci       Date:  2012-10-17       Impact factor: 5.923

8.  Blood type AB predicts promising prognosis in gastric cancer patients with positive preoperative serum CEA.

Authors:  Shuao Xiao; Fan Feng; Li Sun; Lei Cai; Zhen Liu; Shushang Liu; Daiming Fan; Hongwei Zhang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

9.  Gastric cancer in Alaska Native people: A cancer health disparity.

Authors:  Holly A Martinson; Nancy J Shelby; Steven R Alberts; Matthew J Olnes
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

10.  The Value of ABO Blood Group and Complete Blood Count for the Prognosis Analysis of Gastric Cancer Patients.

Authors:  Xiao-Jie Sun; Le Ai; Yang-Chun Feng
Journal:  Onco Targets Ther       Date:  2020-05-25       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.